Pharmacy Medical News about Gastrointestinal Tract Hemorrhage Platelet Aggregation Inhibitors

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09

Hsiao F–Y et al. – In this analysis in patients at high GI risk who were receiving antiplatelet therapy for the secondary prevention of cardiovascular events, aspirin plus a PPI was associated with a reduced risk of recurrent hospitalization for major GI complications. This was not the case for clopidogrel plus a PPI.

Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09 Relevance Score: 77%

Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel
Thrombosis Research, 10/20/09 Relevance Score: 70%

Acidic-store depletion is required for human platelet aggregation
Blood Coagulation & Fibrinolysis, 10/05/09 Relevance Score: 69%

Platelet Aggregation in Intracranial Stents May Mimic In-Stent Restenosis
American Journal of Neuroradiology, 11/02/09 Relevance Score: 68%

Platelet Cyclic Guanosine Monophosphate as a Biomarker of Phosphodiesterase Type 5 Inhibitor Efficacy in the Treatment of Erectile Dysfunction: A Randomized Placebo-Controlled Study
European Urology, 11/05/09 Relevance Score: 67%